HAYWARD, Calif., June 1 /PRNewswire-FirstCall/ -- Solta Medical,
Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics
market, today announced that it will present at the 9th Annual
Needham Healthcare Conference in New York
City. The presentation is scheduled for Wednesday, June 9 at 3:30
pm ET. Stephen J. Fanning, Chairman, President and
Chief Executive Officer, will review the company's business
strategy and recent corporate events at both conferences.
Attendance at these conferences is by invitation only.
Solta will offer a live audio webcast of these presentations
which may be accessed at the Investor Relations section of the
Company's website at www.solta.com. An archived replay for
both will be available for 30 days following each event at
www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a range of
skin issues under the industry's three premier brands: Thermage®,
Fraxel® and Isolaz®. Thermage is an innovative, non-invasive
radiofrequency procedure for tightening and contouring skin. As the
leader in fractional laser technology, Fraxel delivers minimally
invasive clinical solutions to resurface aging and sun damaged
skin. Isolaz is the only laser or light based system indicated for
the treatment of inflammatory acne, comedonal acne, pustular acne,
and mild-to-moderate inflammatory acne. Since 2002, approximately
one million Thermage, Fraxel and Isolaz procedures have been
performed in over 100 countries. For more information about Solta
Medical, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.